Literature DB >> 29936833

Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.

John W Thompson1, Alexander W Sorum1, Linda C Hsieh-Wilson1.   

Abstract

The dynamic posttranslational modification O-linked β- N-acetylglucosamine glycosylation (O-GlcNAcylation) is present on thousands of intracellular proteins in the brain. Like phosphorylation, O-GlcNAcylation is inducible and plays important functional roles in both physiology and disease. Recent advances in mass spectrometry (MS) and bioconjugation methods are now enabling the mapping of O-GlcNAcylation events to individual sites in proteins. However, our understanding of which glycosylation events are necessary for regulating protein function and controlling specific processes, phenotypes, or diseases remains in its infancy. Given the sheer number of O-GlcNAc sites, methods for identifying promising sites and prioritizing them for time- and resource-intensive functional studies are greatly needed. Revealing sites that are dynamically altered by different stimuli or disease states will likely go a long way in this regard. Here, we describe advanced methods for identifying O-GlcNAc sites on individual proteins and across the proteome and for determining their stoichiometry in vivo. We also highlight emerging technologies for quantitative, site-specific MS-based O-GlcNAc proteomics (O-GlcNAcomics), which allow proteome-wide tracking of O-GlcNAcylation dynamics at individual sites. These cutting-edge technologies are beginning to bridge the gap between the high-throughput cataloguing of O-GlcNAcylated proteins and the relatively low-throughput study of individual proteins. By uncovering the O-GlcNAcylation events that change in specific physiological and disease contexts, these new approaches are providing key insights into the regulatory functions of O-GlcNAc in the brain, including their roles in neuroprotection, neuronal signaling, learning and memory, and neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29936833      PMCID: PMC6058732          DOI: 10.1021/acs.biochem.8b00516

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  78 in total

1.  Identification of O-GlcNAc sites on proteins.

Authors:  Stephen A Whelan; Gerald W Hart
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

2.  O-GlcNAc transferase regulates excitatory synapse maturity.

Authors:  Olof Lagerlöf; Gerald W Hart; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

3.  Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity.

Authors:  Boopathy Ramakrishnan; Pradman K Qasba
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

4.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.

Authors:  Michael Boyce; Isaac S Carrico; Anjali S Ganguli; Seok-Ho Yu; Matthew J Hangauer; Sarah C Hubbard; Jennifer J Kohler; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

6.  Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.

Authors:  Nelly Khidekel; Scott B Ficarro; Peter M Clark; Marian C Bryan; Danielle L Swaney; Jessica E Rexach; Yi E Sun; Joshua J Coon; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2007-05-13       Impact factor: 15.040

7.  Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry.

Authors:  Zihao Wang; Namrata D Udeshi; Meaghan O'Malley; Jeffrey Shabanowitz; Donald F Hunt; Gerald W Hart
Journal:  Mol Cell Proteomics       Date:  2009-08-19       Impact factor: 5.911

8.  Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification.

Authors:  Wagner B Dias; Win D Cheung; Zihao Wang; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

9.  O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.

Authors:  Nicholas P Marotta; Yu Hsuan Lin; Yuka E Lewis; Mark R Ambroso; Balyn W Zaro; Maxwell T Roth; Don B Arnold; Ralf Langen; Matthew R Pratt
Journal:  Nat Chem       Date:  2015-10-12       Impact factor: 24.427

10.  O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease.

Authors:  Willayat Y Wani; Xiaosen Ouyang; Gloria A Benavides; Matthew Redmann; Stacey S Cofield; John J Shacka; John C Chatham; Victor Darley-Usmar; Jianhua Zhang
Journal:  Mol Brain       Date:  2017-07-19       Impact factor: 4.041

View more
  9 in total

Review 1.  Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.

Authors:  Chia-Wei Hu; Matthew Worth; Hao Li; Jiaoyang Jiang
Journal:  Chembiochem       Date:  2018-11-12       Impact factor: 3.164

2.  Complementary proteome and glycoproteome access revealed through comparative analysis of reversed phase and porous graphitic carbon chromatography.

Authors:  Daniel G Delafield; Hannah N Miles; Yuan Liu; William A Ricke; Lingjun Li
Journal:  Anal Bioanal Chem       Date:  2022-02-09       Impact factor: 4.478

Review 3.  The dynamic brain N-glycome.

Authors:  Thomas S Klarić; Gordan Lauc
Journal:  Glycoconj J       Date:  2022-03-25       Impact factor: 2.916

Review 4.  Moving beyond the glial scar for spinal cord repair.

Authors:  Elizabeth J Bradbury; Emily R Burnside
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

Review 5.  Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease.

Authors:  Wenyue Wang; Sandeep Gopal; Roger Pocock; Zhicheng Xiao
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

6.  Mammalian brain glycoproteins exhibit diminished glycan complexity compared to other tissues.

Authors:  Sarah E Williams; Maxence Noel; Sylvain Lehoux; Murat Cetinbas; Ramnik J Xavier; Ruslan I Sadreyev; Edward M Scolnick; Jordan W Smoller; Richard D Cummings; Robert G Mealer
Journal:  Nat Commun       Date:  2022-01-12       Impact factor: 17.694

Review 7.  Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury.

Authors:  Jiahua Xie; Farooqahmed S Kittur; P Andy Li; Chiu-Yueh Hung
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

8.  The FUS gene is dual-coding with both proteins contributing to FUS-mediated toxicity.

Authors:  Marie A Brunet; Jean-Francois Jacques; Sonya Nassari; Giulia E Tyzack; Philip McGoldrick; Lorne Zinman; Steve Jean; Janice Robertson; Rickie Patani; Xavier Roucou
Journal:  EMBO Rep       Date:  2020-11-23       Impact factor: 9.071

Review 9.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.